Articles

Using buyer personas to transform online marketing

2nd September 2014

Using buyer personas to transform online marketingMiriam Shaviv

For companies in the pharma sector struggling to become more 'patient-centric' and 'customer-centric' on social media, the creation of buyer personas can be transformative in helping to outline target customers... Read more

What makes an effective communications plan?

1st September 2014

What makes an effective communications plan?Lea Studer

A communications plan gives focus and structure to the numerous aspects of a company's communications. This article examines the elements of an effective communications plan and how best to implement... Read more

Performance coaching - the leadership style that time forgot

29th August 2014

Performance coaching - the leadership style that time forgot Nikki Burgess, Maureen Deehan & Allan Mackintosh

Speakers at recent sales force effectiveness (SFE) conferences have highlighted the importance of line managers coaching sales teams in the field and supporting them with personal development. In a market... Read more

Cancer Drugs Fund budget increased – but pharma prices to be challenge…

28th August 2014

Cancer Drugs Fund budget increased – but pharma prices to be challengedAndrew McConaghie

England's Cancer Drugs Fund is to see its annual budget increased by 40 per cent – but 'excessively priced' drugs could be removed from the list if companies refuse to... Read more

News

UCB’s epilepsy drug approved as monotherapy in US

2nd September 2014

UCB’s epilepsy drug approved as monotherapy in US Linda Banks

The US FDA has approved a supplemental new drug application (sNDA) for UCB's Vimpat (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17... Read more

Xarelto works in new cardioversion indication for AF

2nd September 2014

Xarelto works in new cardioversion indication for AFStaff reporter

Bayer and Janssen's novel oral anticoagulant (NOAC) Xarelto can be used in place of warfarin in atrial fibrillation patients undergoing cardioversion to restore normal heart rhythm, according to a new... Read more

Novo Nordisk to exit inflammatory disease research

2nd September 2014

Novo Nordisk to exit inflammatory disease researchAndrew McConaghie

Novo Nordisk is to exit all research into inflammatory disorders following disappointing results for a rheumatoid arthritis treatment.The Copenhagen-headquartered company has made the decision after ending development of its lead... Read more

Hits and misses highlighted at ESC heart congress

1st September 2014

Hits and misses highlighted at ESC heart congressStaff Reporter

The news from the European Society of Cardiology (ESC) meeting in Barcelona is currently being dominated by Novartis' LCZ696 and Sanofi/Regeneron's alirocumab, but there is a lot more going on... Read more

Audio & Video

Tweetchat: Managing diabetes in the real…

Atlantis Healthcare diabetes Tweetchat


Atlantis Health is working with pharmaphorum to conduct a Tweetchat on the real world challenges patients face in managing... View more

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

Sanofi and Regeneron push positive results for PCSK9 inhibitor

Sanofi and Regeneron have announced positive results from trials of novel drug alirocumab, which targets PCSK9, ... Read more

News

Novartis drug could be breakthrough in heart failure

A new treatment, LCZ696, has produced exceptionally impressive results in cutting risk of death in heart failure... Read more

News

Ice bucket challenge tally nears $100m

The ALS Ice Bucket Challenge has raised a staggering $94.3 million for the motor neurone disease (MND) charity b... Read more

News

Amgen submits BLA to FDA for novel cholesterol drug

Amgen has submitted the first Biologics Licence Application (BLA) to the US FDA for a PCSK9 inhibitor.<... Read more

News

BMS hep C drug approved in Europe

The news in hepatitis C in recent months has all been about Gilead's record-smashing launch of Sovaldi and wh... Read more

News

NICE wants more cost evidence on BI’s diabetes drug

More evidence on the cost-effectiveness of Boehringer Ingelheim's type 2 diabetes drug empagliflozin has been re... Read more

News